[1]PONIKOWSKI P, VOORS A A, ANKER S D, et al.ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure][J].Kardiologia polska, 2016, 74(10):1037-147
[2]RONCO C, RICCI Z.Renal replacement therapies: physiological review[J].Intensive care medicine, 2008, 34(12):2139-46
[3]RONCO C, BELLOMO R.Continuous renal replacement therapies: the need for a standard nomenclature [J]. Contributions to nephrology, 1995, 116: 28-33.[J].Contributions to nephrology, 1995, 116(1):28-33
[4]邬步云, 余燕婷, 季大玺.连续性肾脏替代治疗在中国的发展历程与展望[J].中国血液净化, 2019, 18(09):587-90
[5]MACEDO E, MEHTA R L.Continuous Dialysis Therapies: Core Curriculum 2016[J].American journal of kidney diseases : the official journal of the National Kidney Foundation, 2016, 68(4):645-57
[6]FLEMING G M, ASKENAZI D J, BRIDGES B C, et al.A multicenter international survey of renal supportive therapy during ECMO: the Kidney Intervention During Extracorporeal Membrane Oxygenation (KIDMO) group[J].ASAIO journal (American Society for Artificial Internal Organs), 2012, 58(4):407-14
[7]OSTERMANN M, CONNOR M, JR.KASHANI KContinuous renal replacement therapy during extracorporeal membrane oxygenation: why,when and how?[J].Current opinion in critical care, 2018, 24(6):493-503
[8]ANTONUCCI E, LAMANNA I, FAGNOUL D, et al.The Impact of Renal Failure and Renal Replacement Therapy on Outcome During Extracorporeal Membrane Oxygenation Therapy[J].Artificial organs, 2016, 40(8):746-54
[9]余志辉, 赵慧, 温伟标.体外膜肺氧合支持患者连续性肾替代治疗介入时机对预后影响[J].现代诊断与治疗, 2018, 29(24):4014-5
[10]WHEELER C R, BULLOCK K J.Extracorporeal Membrane Oxygenation[J].Respiratory care, 2023, 68(8):1158-70
[11]KINDGEN-MILLES D, BRANDENBURGER T, DIMSKI T.Regional citrate anticoagulation for continuous renal replacement therapy[J].Current opinion in critical care, 2018, 24(6):450-4
[12]MORABITO S, PISTOLESI V, TRITAPEPE L, et al.Regional citrate anticoagulation for RRTs in critically ill patients with AKI[J].Clinical journal of the American Society of Nephrology : CJASN, 2014, 9(12):2173-88
[13]BAI M, ZHOU M, HE L, et al.Citrate versus heparin anticoagulation for continuous renal replacement therapy: an updated meta-analysis of RCTs[J].Intensive care medicine, 2015, 41(12):2098-110
[14]BORG R, UGBOMA D, WALKER D M, et al.Evaluating the safety and efficacy of regional citrate compared to systemic heparin as anticoagulation for continuous renal replacement therapy in critically ill patients: A service evaluation following a change in practice[J].Journal of the Intensive Care Society, 2017, 18(3):184-92
[15]ZHANG Z, HONGYING N.Efficacy and safety of regional citrate anticoagulation in critically ill patients undergoing continuous renal replacement therapy[J].Intensive care medicine, 2012, 38(1):20-8
[16]GIANI M, SCARAVILLI V, STEFANINI F, et al.Continuous Renal Replacement Therapy in Venovenous Extracorporeal Membrane Oxygenation: A Retrospective Study on Regional Citrate Anticoagulation[J].ASAIO journal (American Society for Artificial Internal Organs), 2020, 66(3):332-8
[17]DUNN W J, SRIRAM S.Filter lifespan in critically ill adults receiving continuous renal replacement therapy: the effect of patient and treatment-related variables[J].Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine, 2014, 16(3):225-31
[18]BRAIN M, WINSON E, ROODENBURG O, et al.Non anti-coagulant factors associated with filter life in continuous renal replacement therapy (CRRT): a systematic review and meta-analysis[J].BMC nephrology, 2017, 18(1):69-96
[19]ZEIDMAN A D.Extracorporeal Membrane Oxygenation and Continuous Kidney Replacement Therapy: Technology and Outcomes - A Narrative Review[J].Advances in chronic kidney disease, 2021, 28(1):29-36
[20]HOFF B M, MAKER J H, DAGER W E, et al.Antibiotic Dosing for Critically Ill Adult Patients Receiving Intermittent Hemodialysis,Prolonged Intermittent Renal Replacement Therapy,and Continuous Renal Replacement Therapy: An Update[J].The Annals of pharmacotherapy, 2020, 54(1):43-55
[21]KARKAR A, RONCO C.Prescription of CRRT: a pathway to optimize therapy[J].Annals of intensive care, 2020, 10(1):32-42
[22]CHEN H, YU R G, YIN N N, et al.Combination of extracorporeal membrane oxygenation and continuous renal replacement therapy in critically ill patients: a systematic review[J].Critical care (London, England), 2014, 18(6):675-686
[23]ASKENAZI D J, SELEWSKI D T, PADEN M L, et al.Renal replacement therapy in critically ill patients receiving extracorporeal membrane oxygenation[J].Clinical journal of the American Society of Nephrology : CJASN, 2012, 7(8):1328-36
[24]DE TYMOWSKI C, AUGUSTIN P, HOUISSA H, et al.CRRT Connected to ECMO: Managing High Pressures[J].ASAIO journal (American Society for Artificial Internal Organs), 2017, 63(1):48-52
[25]HAN S S, KIM H J, LEE S J, et al.Effects of Renal Replacement Therapy in Patients Receiving Extracorporeal Membrane Oxygenation: A Meta-Analysis[J].The Annals of thoracic surgery, 2015, 100(4):1485-95
[26]THAJUDEEN B, KAMEL M, ARUMUGAM C, et al.Outcome of patients on combined extracorporeal membrane oxygenation and continuous renal replacement therapy: a retrospective study[J].The International journal of artificial organs, 2015, 38(3):133-7
[27]SELEWSKI D T, CORNELL T T, LOMBEL R M, et al.Weight-based determination of fluid overload status and mortality in pediatric intensive care unit patients requiring continuous renal replacement therapy[J].Intensive care medicine, 2011, 37(7):1166-73
[28]SWANIKER F, KOLLA S, MOLER F, et al.Extracorporeal life support outcome for 128 pediatric patients with respiratory failure[J].Journal of pediatric surgery, 2000, 35(2):197-202
[29]BLIJDORP K, CRANSBERG K, WILDSCHUT E D, et al.Haemofiltration in newborns treated with extracorporeal membrane oxygenation: a case-comparison study[J].Critical care (London, England), 2009, 13(2):48-55
[30]ANDERSON H L, 3RD, CORAN A G, DRONGOWSKI R A, et al.Extracellular fluid and total body water changes in neonates undergoing extracorporeal membrane oxygenation[J].Journal of pediatric surgery, 1992, 27(8):1003-7
[31]MEYER R J, BROPHY P D, BUNCHMAN T E, et al.Survival and renal function in pediatric patients following extracorporeal life support with hemofiltration[J].Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 2001, 2(3):238-42
[32]PADEN M L, WARSHAW B L, HEARD M L, et al.Recovery of renal function and survival after continuous renal replacement therapy during extracorporeal membrane oxygenation[J].Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 2011, 12(2):153-8
[33]DADO D N, AINSWORTH C R, THOMAS S B, et al.Outcomes among Patients Treated with Renal Replacement Therapy during Extracorporeal Membrane Oxygenation: A Single-Center Retrospective Study[J].Blood purification, 2020, 49(3):341-7
[34]HIRAMATSU T, SHIMIZU S, KOGA H.Prognostic factors in patients treated with extracorporeal membrane oxygenation and continuous renal replacement therapy[J].Perfusion, 2022, 37(6):570-4
[35]刘群, 卢森, 贺宏丽.同时接受体外膜氧合器和连续性肾脏替代治疗患者的临床特点分析[J].中国现代医学杂志, 2023, 33(07):73-8
[36]SAVA? H, GULER S.Prevention of catheter-related bloodstream infections in patients with extracorporeal membrane oxygenation: a literature review[J].Revista da Associacao Medica Brasileira, 2023, 69(10):04-09
